rethinkPeptides Search
Menu
Home / Research library
Research citation

Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.

RPEP-075042023Wadden, Thomas A; Chao, Ariana M; Machineni, Sriram; Kushner, Robert; Ard, Jamy; Srivastava, Gitanjali; Halpern, Bruno; Zhang, Shuyu; Chen, Jiaxun; Bunck, Mathijs C; Ahmad, Nadia N; Forrester, Tammy
evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.

Nature medicine, 29(11), 2909-2918

View on PubMed ↗Publisher’s paper ↗

Citation

Wadden, Thomas A; Chao, Ariana M; Machineni, Sriram; Kushner, Robert; Ard, Jamy; Srivastava, Gitanjali; Halpern, Bruno; Zhang, Shuyu; Chen, Jiaxun; Bunck, Mathijs C; Ahmad, Nadia N; Forrester, Tammy. (2023). Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.. Nature medicine, 29(11), 2909-2918. https://doi.org/10.1038/s41591-023-02597-w